Predicting personalized cumulative live birth following in vitro fertilization.
Anti-Mullerian Hormone
/ blood
Biomarkers
/ blood
Body Mass Index
Databases, Factual
Decision Support Techniques
Female
Fertility
Fertilization in Vitro
Humans
Infertility
/ diagnosis
Live Birth
Male
Maternal Age
Parity
Pregnancy
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
United States
Cumulative live birth
IVF
prediction
Journal
Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
11
06
2021
revised:
14
09
2021
accepted:
14
09
2021
pubmed:
23
10
2021
medline:
1
3
2022
entrez:
22
10
2021
Statut:
ppublish
Résumé
To develop in vitro fertilization (IVF) prediction models to estimate the individualized chance of cumulative live birth at two time points: pretreatment (i.e., before starting the first complete cycle of IVF) and posttreatment (i.e., before starting the second complete cycle of IVF in those couples whose first complete cycle was unsuccessful). Population-based cohort study. National data from the Society for Assisted Reproductive Technology (SART) Clinic Outcome Reporting System. Based on 88,614 women who commenced IVF treatment using their own eggs and partner's sperm in SART member clinics. Not applicable. The pretreatment model estimated the cumulative chance of a live birth over a maximum of three complete cycles of IVF, whereas the posttreatment model did so over the second and third complete cycles. One complete cycle included all fresh and frozen embryo transfers resulting from one episode of ovarian stimulation. We considered the first live birth episode, including singletons and multiple births. Pretreatment predictors included woman's age (35 years vs. 25 years, adjusted odds ratio 0.69, 95% confidence interval 0.66-0.73) and body mass index (35 kg/m The focus of previous IVF prediction models based on US data has been cumulative live birth excluding cycles involving frozen embryos. These novel prediction models provide clinically relevant estimates that could help clinicians and couples plan IVF treatment at different points in time.
Identifiants
pubmed: 34674824
pii: S0015-0282(21)02053-7
doi: 10.1016/j.fertnstert.2021.09.015
pii:
doi:
Substances chimiques
Biomarkers
0
Anti-Mullerian Hormone
80497-65-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
326-338Informations de copyright
Copyright © 2021 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.